Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How this can lead to improved diagnosis, treatment, and clinical outcomes.

Episode 58 November 05, 2021 01:27:22
Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How this can lead to improved diagnosis, treatment, and clinical outcomes.
MitoAction Expert Series
Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How this can lead to improved diagnosis, treatment, and clinical outcomes.

Nov 05 2021 | 01:27:22

/

Show Notes

Join MitoAction and Dr. Richard Boles for our November Mito Expert Series presentation titled: Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How this can lead to improved diagnosis, treatment, and clinical outcomes.

Dr. Boles will talk with us about the Neurabilities NeuroGenomics Program and how we can make exact diagnoses using whole genome sequencing, translate that into treatments, and improve clinical outcomes. He will also share information with us about the NeuroNeeds product line.

Click here for the accompanying slides.

Other Episodes

Episode

March 12, 2025 01:49:39
Episode Cover

Expert Series: Rhabdo Roundtable for teens and adults with FAODs.

Listen

Episode

March 18, 2022 00:52:51
Episode Cover

MELAS Spectrum Disorders and Sonlicromanol: Progress Update

Join MitoAction and Dr. Jan Smeitink, CEO of Khondrion for our our March Expert Series presentation. MELAS spectrum (m.3243A>G) disorders belong to the most...

Listen

Episode 0

June 05, 2020 01:39:01
Episode Cover

The Mito Cocktail Explained - Saad Dinno & Dr. Virginia Tawa - 3/7/08

Saad Dinno, RPh, a compounding pharmacist at Acton Pharmacy and Dr. Virginia Tawa, PharmD, discussed the ingredients which make up the mysterious “Mito Cocktail.”

Listen